Cargando…

A computational approach for rational discovery of inhibitors for non-structural protein 1 of SARS-CoV-2

BACKGROUND: Non-structural protein 1 (Nsp1), a virulence agent of SARS-CoV-2, has emerged as an important target for drug discovery. Nsp1 shuts down the host gene function by associating with the 40S ribosomal subunit. METHODS: Molecular interactions, drug-likeness, physiochemical property predictio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Rahul, Bhardwaj, Vijay Kumar, Das, Pralay, Purohit, Rituraj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184359/ https://www.ncbi.nlm.nih.gov/pubmed/34144270 http://dx.doi.org/10.1016/j.compbiomed.2021.104555

Ejemplares similares

Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs
por: Bhardwaj, Vijay Kumar, et al.
Publicado: (2021)

Benchmarking the ability of novel compounds to inhibit SARS-CoV-2 main protease using steered molecular dynamics simulations
por: Singh, Rahul, et al.
Publicado: (2022)

Potential of turmeric-derived compounds against RNA‐dependent RNA polymerase of SARS‐CoV‐2: An in-silico approach
por: Singh, Rahul, et al.
Publicado: (2021)

Identification of potential plant bioactive as SARS-CoV-2 Spike protein and human ACE2 fusion inhibitors
por: Singh, Rahul, et al.
Publicado: (2021)

In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors
por: Singh, Rahul, et al.
Publicado: (2021)

Bioactive Molecules of Tea as Potential Inhibitors for RNA-Dependent RNA Polymerase of SARS-CoV-2
por: Bhardwaj, Vijay Kumar, et al.
Publicado: (2021)

An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2
por: Sharma, Jatin, et al.
Publicado: (2021)

A ricin-based peptide BRIP from Hordeum vulgare inhibits M(pro) of SARS-CoV-2
por: Kashyap, Prakriti, et al.
Publicado: (2022)

Target identification, screening and in vivo evaluation of pyrrolone-fused benzosuberene compounds against human epilepsy using Zebrafish model of pentylenetetrazol-induced seizures
por: Tanwar, Garima, et al.
Publicado: (2019)

Theaflavin 3-gallate inhibits the main protease (M(pro)) of SARS-CoV-2 and reduces its count in vitro
por: Chauhan, Mahima, et al.
Publicado: (2022)

COVID-19: Rational discovery of the therapeutic potential of Melatonin as a SARS-CoV-2 main Protease Inhibitor
por: Feitosa, Eduardo L, et al.
Publicado: (2020)

Identification of potential edible mushroom as SARS-CoV-2 main protease inhibitor using rational drug designing approach
por: Sen, Debanjan, et al.
Publicado: (2022)

Covalent inhibitors: a rational approach to drug discovery
por: Sutanto, Fandi, et al.
Publicado: (2020)

Structural Perturbations due to Mutation (H1047R) in Phosphoinositide-3-kinase (PI3Kα) and Its Involvement in Oncogenesis: An in Silico Insight
por: Sharma, Jatin, et al.
Publicado: (2019)

A Computer-Aided Approach for the Discovery of D-Peptides as Inhibitors of SARS-CoV-2 Main Protease
por: Hernández González, Jorge E., et al.
Publicado: (2022)

Interactions between main protease of SARS-CoV-2 and testosterone or progesterone using computational approach
por: Vishvakarma, Vijay Kumar, et al.
Publicado: (2022)

Rational Computational Approaches in Drug Discovery: Potential Inhibitors for Allosteric Regulation of Mutant Isocitrate Dehydrogenase-1 Enzyme in Cancers
por: Thamim, Masthan, et al.
Publicado: (2023)

Drug repurposing against SARS-CoV-2 using computational approaches
por: Kumar, Sumit, et al.
Publicado: (2022)

Design of hACE2-based small peptide inhibitors against spike protein of SARS-CoV-2: a computational approach
por: Dhingra, Naveen, et al.
Publicado: (2023)

Multistep rational molecular design and combined docking for discovery of novel classes of inhibitors of SARS-CoV-2 main protease 3CLpro
por: Tumskiy, Roman S., et al.
Publicado: (2021)

Naturally occurring anthraquinones as potential inhibitors of SARS-CoV-2 main protease: an integrated computational study
por: Das, Sourav, et al.
Publicado: (2022)

Drug Discovery in Low Data Regimes: Leveraging a Computational Pipeline for the Discovery of Novel SARS-CoV-2 Nsp14-MTase Inhibitors
por: Nigam, AkshatKumar, et al.
Publicado: (2023)

Computational approaches for rational design of proteins with novel functionalities
por: Tiwari, Manish Kumar, et al.
Publicado: (2012)

Rational design of the zonulin inhibitor AT1001 derivatives as potential anti SARS-CoV-2
por: Di Micco, Simone, et al.
Publicado: (2022)

Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors
por: Štefek, Milan, et al.
Publicado: (2023)

Discovery of M Protease Inhibitors Encoded by SARS-CoV-2
por: Hung, Hui-Chen, et al.
Publicado: (2020)

Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors
por: Huff, Sarah, et al.
Publicado: (2021)

Production of Proteins of the SARS-CoV-2 Proteome for Drug Discovery
por: Kim, Choon, et al.
Publicado: (2021)

Computationally driven discovery of SARS-CoV-2 M(pro) inhibitors: from design to experimental validation
por: El Khoury, Léa, et al.
Publicado: (2022)

Drug repurposing and computational modeling for discovery of inhibitors of the main protease (M(pro)) of SARS-CoV-2
por: Silva, José Rogério A., et al.
Publicado: (2021)

Discovery of Small-Molecule Inhibitors of SARS-CoV-2 Proteins Using a Computational and Experimental Pipeline
por: Lau, Edmond Y., et al.
Publicado: (2021)

Unravelling Vitamin B12 as a potential inhibitor against SARS-CoV-2: A computational approach
por: Pandya, Medha, et al.
Publicado: (2022)

Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants
por: Acharya, Arpan, et al.
Publicado: (2021)

Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2
por: Tripathi, Praveen Kumar, et al.
Publicado: (2020)

Rational Discovery of Antiviral Whey Protein-Derived Small Peptides Targeting the SARS-CoV-2 Main Protease
por: Gambacorta, Nicola, et al.
Publicado: (2022)

Mechanochemical Approach towards Multi-Functionalized 1,2,3-Triazoles and Anti-Seizure Drug Rufinamide Analogs Using Copper Beads
por: Bhattacherjee, Dhananjay, et al.
Publicado: (2022)

Rational design of flavonoid based potential inhibitors targeting SARS-CoV 3CL protease for the treatment of COVID-19
por: Bhati, Shipra, et al.
Publicado: (2021)

Emerging Computational Methods for the Rational Discovery of Allosteric Drugs
por: Wagner, Jeffrey R., et al.
Publicado: (2016)

Rational approach to drug discovery for human schistosomiasis
por: LoVerde, Philip T., et al.
Publicado: (2021)

Analogue discovery of safer alternatives to HCQ and CQ drugs for SAR-CoV-2 by computational design
por: Sinha, Meetali, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ddg13h46139ptp5q6hq5me8fib